Aytu Biopharma, Inc (AYTU) insider trading
Every open-market stock purchase and sale by Aytu Biopharma, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- No open-market insider trades in the last 12 months.
- Last insider buy: Joshua R. Disbrow (CEO), $100K, 16 months ago.
Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales). Last close $1.98 on Oct 22, 2026.
Recent AYTU insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jul 28, 2026 | Vivian H Liu (Director) | Bought (not open market) | — |
| Jul 28, 2026 | Abhinav Jain (Director) | Bought (not open market) | — |
| Jul 28, 2026 | Carl Dockery (Director) | Bought (not open market) | — |
| Jul 28, 2026 | John Donofrio Jr. (Director) | Bought (not open market) | — |
| Jul 28, 2026 | Greg Pyszczymuka (C-suite exec) | Bought (not open market) | — |
| Jul 28, 2026 | Jarrett Disbrow (C-suite exec) | Bought (not open market) | — |
| Jul 28, 2026 | Joshua R. Disbrow (CEO) | Bought (not open market) | — |
| Jul 28, 2026 | Ryan J Selhorn (CFO) | Bought (not open market) | — |
Who's trading AYTU
- Ryan J Selhorn, CFO: other filings, last Jul 28, 2026
- Jarrett Disbrow, C-suite exec: other filings, last Jul 28, 2026
- Joshua R. Disbrow, CEO: other filings, last Jul 28, 2026
- John Donofrio Jr., Director: other filings, last Jul 28, 2026
- Abhinav Jain, Director: other filings, last Jul 28, 2026
- Vivian H Liu, Director: other filings, last Jul 28, 2026
- Carl Dockery, Director: other filings, last Jul 28, 2026
- Greg Pyszczymuka, C-suite exec: other filings, last Jul 28, 2026
Get free alerts when an insider at Aytu Biopharma, Inc files a new trade →